ovascience inc (OVAS:NASDAQ GM)

Executive Profile*

Background*

Dr. Michelle Dipp, M.D., Ph.D. founded OvaScience, Inc. in April 2011 and has been its Chief Executive Officer since June 2011, President since September 2011. Dr. Dipp is a Co-Founder of Verastem, Inc. She is the Founder and Partner at Longwood Founders Management, LLC. Dr. Dipp served as a Senior Vice President and Head of the CEEDD at GlaxoSmithKline. She served as an Associate Director of Strategic Development and Vice President of Corporate Development at Sirtris ... Pharmaceuticals, Inc. Dr. Dipp led the successful acquisition of Sirtris by GSK in June 2008 for $720 million. Before joining Sirtris as a founding employee, she worked in healthcare private equity at The Wellcome Trust. Dr. Dipp serves on the Beth Israel Deaconess Medical Center Board of Trustees, the Boston Symphony Orchestra Board of Overseers and the Board of Directors of the City on a Hill Charter School in Roxbury. She has been a Director of OvaScience, Inc. since July 2011. She did her post-doctoral research in the departments of Pharmacology and Cardiothoracic Surgery, John Radcliffe Hospital, Oxford. Dr. Dipp holds an M.D. from the Oxford University Medical School and a Ph.D. in Physiology from the University of Oxford.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
OVAS:US	$11.50 USD	-0.50

COMPETITOR COMPENSATION